In the lymphadenitis group, as in the lymphoma group, two genes of the core of the transcriptomic C. burnetii-NHL signature, REL and SP100, were significantly upmodulated when compared to the control group. This evidence concerns the gene REL and non-Hodgkin lymphoma.